The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age

被引:2
作者
Vanetti, Claudia [1 ]
Lampasona, Vito [2 ]
Stracuzzi, Marta [3 ]
Fenizia, Claudio [1 ,4 ]
Biasin, Mara [1 ]
Saulle, Irma [1 ,4 ]
Limanaqi, Fiona [1 ,4 ]
Abdelsalam, Ahmed [1 ,5 ]
Loretelli, Cristian [1 ,5 ]
Paradiso, Laura [6 ]
Longoni, Emma [6 ]
Barcellini, Lucia [6 ]
Piemonti, Lorenzo [2 ]
Marzinotto, Ilaria [2 ]
Dispinseri, Stefania [7 ]
Amendola, Antonella [8 ]
Fappani, Clara [8 ]
Tanzi, Elisabetta [8 ]
Clerici, Mario Salvatore [4 ,9 ]
Scarlatti, Gabriella [7 ]
Zuccotti, Gian Vincenzo [6 ]
Giacomet, Vania [3 ]
Trabattoni, Daria [1 ]
机构
[1] Univ Milan, Dept Biomed & Clin Sci, I-20157 Milan, Italy
[2] IRCCS Osped San Raffaele, Diabet Res Inst, I-20132 Milan, Italy
[3] Osped L Sacco, Paediat Infect Dis Unit, I-20157 Milan, Italy
[4] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy
[5] Univ Milan, Int Ctr T1D, Paediat Clin Res Ctr Romeo & Enrica Invernizzi, I-20157 Milan, Italy
[6] Osped Bambini V Buzzi, Dept Paediat, I-20154 Milan, Italy
[7] IRCCS Osped San Raffaele, Viral Evolut & Transmiss Unit, I-20132 Milan, Italy
[8] Univ Milan, Dept Hlth Sci, I-20133 Milan, Italy
[9] IRCCS Fdn Don Carlo Gnocchi, I-20148 Milan, Italy
关键词
COVID-19; SARS-CoV-2; infection; children; immune response;
D O I
10.3390/ijms24076779
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Coronavirus disease 19 (COVID-19) is clinically less severe in children, even if the wide variety and degree of severity of symptoms reported in children pose a still-unresolved challenge for clinicians. We performed an in-depth analysis of the immunological profiles of 18 hospitalized SARS-CoV-2-infected children, whose results were compared to those obtained from 13 age- and sex-matched healthy controls (HC). The patients were categorized as paucisymptomatic/moderate (55.6%) or severe/critical (44.5%) according to established diagnostic criteria and further stratified into the categories of infants (1-12 months), children (1-12 years), and adolescents (>12 years). We assessed SARS-CoV-2-specific RBD antibodies (Ab), neutralizing antibodies (nAb), and circulating cytokines/chemokines in the plasma, and the SARS-CoV-2-specific immune response was measured in PBMCs by gene expression and secretome analyses. Our results showed peculiar circulating cytokine/chemokine profiles among patients sharing a similar clinical phenotype. A cluster of patients consisting of infants with severe symptoms presented hyperinflammatory profiles, together with extremely polarized antibody profiles. In a second cluster consisting of paucisymptomatic patients, a less pronounced increase in the level of inflammatory cytokines, together with an association between the selected cytokines and humoral responses, was observed. A third cluster, again consisting of paucisymptomatic patients, showed a circulating cytokine/chemokine profile which overlapped with that of the HC. The SARS-CoV-2-stimulated production of pro-inflammatory proteins, T lymphocyte activation, and migration-specific proteins, were significantly increased in SARS-CoV-2-infected children compared to the HC. Our findings suggest that immune response activation in the course of SARS-CoV-2 infection in children is directly correlated with clinical severity and, to a lesser extent, age.
引用
收藏
页数:16
相关论文
共 36 条
  • [31] Interleukin-6 levels in children developing SARS-CoV-2 infection
    Soraya, Gita Vita
    Ulhaq, Zulvikar Syambani
    [J]. PEDIATRICS AND NEONATOLOGY, 2020, 61 (03) : 253 - 254
  • [32] Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults A Systematic Review and Meta-analysis
    Viner, Russell M.
    Mytton, Oliver T.
    Bonell, Chris
    Melendez-Torres, G. J.
    Ward, Joseph
    Hudson, Lee
    Waddington, Claire
    Thomas, James
    Russell, Simon
    van der Klis, Fiona
    Koirala, Archana
    Ladhani, Shamez
    Panovska-Griffiths, Jasmina
    Davies, Nicholas G.
    Booy, Robert
    Eggo, Rosalind M.
    [J]. JAMA PEDIATRICS, 2021, 175 (02) : 143 - 156
  • [33] Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum
    Weisberg, Stuart P.
    Connors, Thomas J.
    Zhu, Yun
    Baldwin, Matthew R.
    Lin, Wen-Hsuan
    Wontakal, Sandeep
    Szabo, Peter A.
    Wells, Steven B.
    Dogra, Pranay
    Gray, Joshua
    Idzikowski, Emma
    Stelitano, Debora
    Bovier, Francesca T.
    Davis-Porada, Julia
    Matsumoto, Rei
    Poon, Maya Meimei Li
    Chait, Michael
    Mathieu, Cyrille
    Horvat, Branka
    Decimo, Didier
    Hudson, Krystalyn E.
    Dei Zotti, Flavia
    Bitan, Zachary C.
    La Carpia, Francesca
    Ferrara, Stephen A.
    Mace, Emily
    Milner, Joshua
    Moscona, Anne
    Hod, Eldad
    Porotto, Matteo
    Farber, Donna L.
    [J]. NATURE IMMUNOLOGY, 2021, 22 (01) : 25 - 31
  • [34] who, Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19
  • [35] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
    Zhou, Fei
    Yu, Ting
    Du, Ronghui
    Fan, Guohui
    Liu, Ying
    Liu, Zhibo
    Xiang, Jie
    Wang, Yeming
    Song, Bin
    Gu, Xiaoying
    Guan, Lulu
    Wei, Yuan
    Li, Hui
    Wu, Xudong
    Xu, Jiuyang
    Tu, Shengjin
    Zhang, Yi
    Chen, Hua
    Cao, Bin
    [J]. LANCET, 2020, 395 (10229) : 1054 - 1062
  • [36] Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
    Zimmermann, Petra
    Curtis, Nigel
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (05) : 429 - 439